Clin2
NCT07619001Worth exploringNot yet recruiting

Study of AK104 drug similarity in healthy Chinese men

Healthy Male Adults Participants

Treatments studied

This study tests how a new drug (AK104) is processed in the body by comparing it to a known similar drug. It is for healthy men and aims to make sure the new drug behaves the same, which could help in future treatments for conditions like cancer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
158 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a healthy male aged 18 to 45 years.
  • Your body mass index (BMI) must be between 19.0 and 26.0, and your weight must be 55 to 75 kg.
  • You need to be in good health with no major chronic conditions, cancer history, infections, or autoimmune diseases.
  • You must not have used any medications (including herbal supplements) or vaccines in the last 2 weeks to 3 months.
  • You must be willing to avoid smoking, alcohol, caffeine, grapefruit, and certain foods during the study, and use contraception or stay abstinent for 6 months after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06947109Not yet recruiting· Phase 1
Testing AK139 in healthy volunteers for safety

This early-phase trial tests a new medication called AK139 in healthy volunteers to see if it is safe and how the body handles it. Participation helps researchers understand the drug before it is studied in people with a specific disease.

Hangzhou, Zhejiang
NCT07872579Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.

Wuxi, Jiangsu
NCT07432698Not yet recruiting· Phase 1
Safety study of AK0406 injection in healthy adults

This study tests a new medicine called AK0406, given as an injection, to see if it is safe and how the body handles it in healthy volunteers. It helps find the right dose for future studies.

Bayswater, Victoria
NCT06996704Recruiting· Phase 1
Study of AK0610 in healthy adults

This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.

Jinan, Shandong
NCT07764705Not yet recruiting· Phase 1
Study of a new drug in healthy men

This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.

NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria

Hear when a new Healthy Male Adults Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.